Featured Transactions

View All
M&A
Financial Sponsor Solutions / Healthcare
Acquisition of Esperion
Up to $1.1bn
Pending
M&A
Financial Sponsor Solutions / Healthcare
Acquisition of Thermo Fisher Scientific's microbiology division
$1.1bn
Pending
M&A
Healthcare
Sale to Eli Lilly and Company
Up to $3.8bn
Pending
M&A
Financial Sponsor Solutions / Healthcare
A portfolio company of Gryphion Capital, sale to Antin Infrastructure Partners
N/A
2026
M&A
Financial Sponsor Solutions / Healthcare
Acquisition of Dentalcorp
N/A
2026
M&A
Healthcare
Sale to Qualtrics International
$6.8bn
2026
M&A
Healthcare
Potential majority sale to ARCHIMED and La Caisse
N/A
2026
M&A
Healthcare
Sale to Eli Lilly
$1.2bn
2026
M&A
Healthcare
Potential acquisition of significant minority stake in Sebia
N/A
2026
M&A / Capital Structure Advisory
Healthcare
Sale to TTAM Research Institute pursuant to its restructuring
N/A
2025
M&A
Healthcare
Sale to Roche
Up to $3.5bn
2025
Capital Markets
Healthcare
IPO
N/A
2025

View More

Our Strategic Alliances

MA Moelis Australia

Moelis & Company provides investment banking advice in Australia through our strategic alliance with MA Moelis Australia, the Corporate Advisory and Equities division of MA Financial Group, an Australian Stock Exchange (ASX) listed firm. MA Moelis Australia provides financial advice for clients across M&A and strategic advisory, equity and debt capital markets, capital structure advisory, equities research and trading.

Learn more about MA Moelis Australia here.

Learn more about MA Financial Group here.

Alfaro, Dávila y Scherer, S.C.

Moelis & Company has a strategic alliance with Alfaro, Dávila y Scherer, S.C. (“ADS”), the leading independent strategic and financial advisory firm in Mexico, to provide advisory services to our global client base with a focus on Mexican cross-border transactions. Founded in 2003, ADS advises a select number of clients on strategic mergers, acquisitions, divestitures, capital raising and financial restructurings.

Learn more about ADS team here.